14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
SBEV vs KTTA: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Pasithea Therapeutics Corp. (KTTA) is the stronger overall head-to-head candidate over Splash Beverage Group, Inc. (SBEV) in the Tradestie Institutional Equity Comparison Engine, winning 5–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). SBEV carries a Unified Composite Score of 36.4/100 (SELL) at $0.47 (N/M Forward P/E, -23888.5% operating margin), whereas KTTA carries 42.1/100 (HOLD) at $0.48 (N/M Forward P/E, 0.0% operating margin).
Technical & Structure Timing Caution: SBEV trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 66.6); meanwhile KTTA is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Competes within the Biotechnology value chain with $17.7M market capitalization and 0.0% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ SBEV vs KTTA Key Questions & Quantitative Answers
As of Nov 20, 2026, Pasithea Therapeutics Corp. (KTTA) is the stronger overall head-to-head candidate over Splash Beverage Group, Inc. (SBEV) in the Tradestie Institutional Equity Comparison Engine, winning 5–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). SBEV carries a Unified Composite Score of 36.4/100 (SELL) at $0.47 (N/M Forward P/E, -23888.5% operating margin), whereas KTTA carries 42.1/100 (HOLD) at $0.48 (N/M Forward P/E, 0.0% operating margin). Technical & Structure Timing Caution: SBEV trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 66.6); meanwhile KTTA is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
KTTA leads the Growth & Scale pillar: SBEV posts -93.8% YoY revenue growth and +0.0% YoY earnings growth on $8,684 TTM revenue (N/A gross margin, -23888.5% operating margin), compared with KTTA at +1498.1% YoY revenue growth and +0.0% YoY earnings growth on $486,559 TTM revenue (-0.5% gross margin, 0.0% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), SBEV cumulative revenue shifted +100.0% while KTTA shifted N/A. In operating R&D and SG&A reinvestment, SBEV deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for KTTA.
KTTA screens cheaper on headline valuation multiples. SBEV trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin), whereas KTTA trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 36.3x EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SBEV (-1130.2% ROE) versus KTTA (-88.8% ROE) capital efficiency.
In options market volatility and institutional positioning, SBEV carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-1.41β · 136% Vol realized risk). By comparison, KTTA carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.68β · 185% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.